Cargando…
Molecular Network Analysis of the Urinary Proteome of Alzheimer's Disease Patients
BACKGROUND/AIMS: The identification of predictive biomarkers for Alzheimer's disease (AD) from urine would aid in screening for the disease, but information about biological and pathophysiological changes in the urine of AD patients is limited. This study aimed to explore the comprehensive prof...
Autores principales: | Watanabe, Yumi, Hirao, Yoshitoshi, Kasuga, Kensaku, Tokutake, Takayoshi, Semizu, Yuka, Kitamura, Kaori, Ikeuchi, Takeshi, Nakamura, Kazutoshi, Yamamoto, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477484/ https://www.ncbi.nlm.nih.gov/pubmed/31043964 http://dx.doi.org/10.1159/000496100 |
Ejemplares similares
-
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020) -
Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study
por: Watanabe, Yumi, et al.
Publicado: (2021) -
Urinary proteome profiles associated with cognitive decline in community elderly residents—A pilot study
por: Watanabe, Yumi, et al.
Publicado: (2023) -
A Patient with Fragile X-Associated Tremor/Ataxia Syndrome Presenting with Executive Cognitive Deficits and Cerebral White Matter Lesions
por: Kasuga, Kensaku, et al.
Publicado: (2011) -
Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)